[The study of the efficacy of Botulinum toxin type A in patients with poststroke upper-limb spasticity ULIS-II: an analysis of Russian patients]

Autor: Pokhabov Dv, Shperling Lp, Khat'kova Se, Korenko La, Popov Dv, Poznyakova Ev, Khasanova Dr, Antipova Ln

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 115(7)

To assess the efficacy of Botulinum toxin type A (BoNT-A) injections in routine practice.An international, post-marketing, multi-center, observational, prospective, longitudinal study included patients ≥18 years with poststroke upper-limb spasticit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::131c61773ae2834ac2484a35c906f37d
https://pubmed.ncbi.nlm.nih.gov/26356520

[Tremor-dominant form of Parkinson's disease].

Autor: Zalyalova ZA; Kazan State Medical University, Kazan, Russia.; Republican Consultative and Diagnostic Center for Extrapyramidal Pathology and Botulinum Therapy, Kazan, Russia., Katunina EA; Pirogov Russian National Research Medical University, Moscow, Russia.; Federal Center for Brain and Neurotechnology, Moscow, Russia., Pokhabov DV; Center for Innovative Neurology, Extrapyramidal Diseases and Botulinum Therapy, Krasnoyarsk, Russia.; Voino-Yasnevetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russia., Munasipova SE; Kazan State Medical University, Kazan, Russia.; Republican Consultative and Diagnostic Center for Extrapyramidal Pathology and Botulinum Therapy, Kazan, Russia., Ermakova MM; Kazan State Medical University, Kazan, Russia.

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2024; Vol. 124 (4), pp. 28-35.

[Postural stability and walking in Parkinson's disease].

Autor: Pokhabov DV; Federal Clinical Scientifical Center of the Federal Medical Biological Agency, Krasnoyarsk, Russia.; Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russia., Tunik ME; Federal Clinical Scientifical Center of the Federal Medical Biological Agency, Krasnoyarsk, Russia., Pokhabov DD; Federal Clinical Scientifical Center of the Federal Medical Biological Agency, Krasnoyarsk, Russia.; Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russia., Katunina EA; Pirogov Russian National Research Medical University, Moscow, Russia.; Federal Center of Brain and Neurotechnologies of the Federal Medical Biological Agency, Moscow, Russia., Zalyalova ZA; Kazan State Medical University, Kazan, Russia.; Hospital for War Veterans, Kazan, Russia.

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2023; Vol. 123 (11), pp. 29-32.

[Efficacy and safety of antiCD20 monoclonal antibody divozilimab during 48-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS].

Autor: Boyko AN; Pirogov Russian National Research Medical University, Moscow, Russia.; Federal Center of Brain and Neurotechnologies of the Federal Medical Biological Agency, Moscow, Russia., Alifirova VM; Siberian State Medical University, Tomsk, Russia., Lukashevich IG; City Clinical Hospital No. 1, Chelyabinsk, Russia., Goncharova ZA; Rostov State Medical University, Rostov-on-Don, Russia., Greshnova IV; Ulyanovsk Regional Clinical Hospital, Ulyanovsk, Russia., Zaslavsky LG; Leningrad Regional Clinical Hospital, St. Petersburg, Russia., Kotov SV; Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russia., Malkova NA; State Novosibirsk Regional Clinical Hospital, Novosibirsk, Russia., Mishin GN; Pyatigorsk City Clinical Hospital No. 2, Pyatigorsk, Russia., Parshina EV; Semashko Nizhny Novgorod Regional Clinical Hospital, Nizhny Novgorod, Russia., Poverennova IY; Seredavin Samara Regional Clinical Hospital, Samara, Russia., Prakhova LN; N. Bechtereva Institute of the Human Brain, St. Petersburg, Russia., Sivertseva SA; Medical and Sanitary unit «Neftyanik», Tyumen, Russia., Smagina IV; Regional Clinical Hospital, Barnaul, Russia., Totolyan NA; Pavlov First Saint Petersburg State Medical University, St. Petersburg, Russia., Trinitatsky YV; Rostov Regional Clinical Hospital, Rostov-on-Don, Russia., Trushnikova TN; Wagner Perm State Medical University, Perm, Russia., Khabirov FA; Republican Clinical Nerological Center, Kazan, Russia., Chefranova JY; Belgorod Regional Clinical Hospital of St. Joasaph, Belgogrod, Russia., Shchur SG; Municipal Filatov Clinical Hospital No. 15, Moscow, Russia., Dudin VA; Center for Cardiology and Neurology», Kirov, Russia., Pokhabov DV; Federal Siberian Scientific and Clinical Center, Krasnoyarsk, Russia., Bolsun DD; JSC BIOCAD, St. Petersburg, Russia., Eremeeva AV; JSC BIOCAD, St. Petersburg, Russia., Linkova YN; JSC BIOCAD, St. Petersburg, Russia., Zinkina-Orikhan AV; JSC BIOCAD, St. Petersburg, Russia.

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2023; Vol. 123 (7. Vyp. 2), pp. 43-52.

[Dynamics of cognitive impairments during L-dopa therapy in Parkinson's disease].

Autor: Ismailova SB; Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russia.; Federal Siberian Research Clinical Center under the Federal Medical and Biological Agency, Krasnoyarsk, Russia., Prokopenko SV; Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russia.; Federal Siberian Research Clinical Center under the Federal Medical and Biological Agency, Krasnoyarsk, Russia., Pokhabov DV; Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russia.; Federal Siberian Research Clinical Center under the Federal Medical and Biological Agency, Krasnoyarsk, Russia., Mosaleva EI; Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russia., Alekseenko PV; Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russia., Zhumzhanov IM; Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russia.

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2021; Vol. 121 (7), pp. 36-41.